2018-2023 Global Drugs for Anti-Infective Consumption Market Report

October 2018 | 166 pages | ID: 2674EA4A931EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Anti-Infective market for 2018-2023.
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.

Over the next five years, LPI(LP Information) projects that Drugs for Anti-Infective will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Anti-Infective market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• OTC
• Rx Drugs

Segmentation by application:

• Hospital
• Drugs Store
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis AG
• Gilead Sciences
• Abbott
• Wyeth
• Sanofi-Aventis
• Bristol-Myers Squibb
• Johnson
• Roche Pharma AG
• Nanosphere
• NanoViricides
• Novabay Pharmaceuticals
• Obetech
• Optimer Pharmaceuticals
• Basilea Pharmaceutica AG
• Daiichi Sankyo
• MerLion Pharma
• Theravance

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Drugs for Anti-Infective consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Drugs for Anti-Infective market by identifying its various subsegments.
• Focuses on the key global Drugs for Anti-Infective manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Drugs for Anti-Infective with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Drugs for Anti-Infective submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL DRUGS FOR ANTI-INFECTIVE CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Anti-Infective Consumption 2013-2023
  2.1.2 Drugs for Anti-Infective Consumption CAGR by Region
2.2 Drugs for Anti-Infective Segment by Type
  2.2.1 OTC
  2.2.2 Rx Drugs
2.3 Drugs for Anti-Infective Consumption by Type
  2.3.1 Global Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
  2.3.2 Global Drugs for Anti-Infective Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Drugs for Anti-Infective Sale Price by Type (2013-2018)
2.4 Drugs for Anti-Infective Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
  2.4.3 Other
2.5 Drugs for Anti-Infective Consumption by Application
  2.5.1 Global Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
  2.5.2 Global Drugs for Anti-Infective Value and Market Share by Application (2013-2018)
  2.5.3 Global Drugs for Anti-Infective Sale Price by Application (2013-2018)

3 GLOBAL DRUGS FOR ANTI-INFECTIVE BY PLAYERS

3.1 Global Drugs for Anti-Infective Sales Market Share by Players
  3.1.1 Global Drugs for Anti-Infective Sales by Players (2016-2018)
  3.1.2 Global Drugs for Anti-Infective Sales Market Share by Players (2016-2018)
3.2 Global Drugs for Anti-Infective Revenue Market Share by Players
  3.2.1 Global Drugs for Anti-Infective Revenue by Players (2016-2018)
  3.2.2 Global Drugs for Anti-Infective Revenue Market Share by Players (2016-2018)
3.3 Global Drugs for Anti-Infective Sale Price by Players
3.4 Global Drugs for Anti-Infective Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Drugs for Anti-Infective Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Drugs for Anti-Infective Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DRUGS FOR ANTI-INFECTIVE BY REGIONS

4.1 Drugs for Anti-Infective by Regions
  4.1.1 Global Drugs for Anti-Infective Consumption by Regions
  4.1.2 Global Drugs for Anti-Infective Value by Regions
4.2 Americas Drugs for Anti-Infective Consumption Growth
4.3 APAC Drugs for Anti-Infective Consumption Growth
4.4 Europe Drugs for Anti-Infective Consumption Growth
4.5 Middle East & Africa Drugs for Anti-Infective Consumption Growth

5 AMERICAS

5.1 Americas Drugs for Anti-Infective Consumption by Countries
  5.1.1 Americas Drugs for Anti-Infective Consumption by Countries (2013-2018)
  5.1.2 Americas Drugs for Anti-Infective Value by Countries (2013-2018)
5.2 Americas Drugs for Anti-Infective Consumption by Type
5.3 Americas Drugs for Anti-Infective Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Anti-Infective Consumption by Countries
  6.1.1 APAC Drugs for Anti-Infective Consumption by Countries (2013-2018)
  6.1.2 APAC Drugs for Anti-Infective Value by Countries (2013-2018)
6.2 APAC Drugs for Anti-Infective Consumption by Type
6.3 APAC Drugs for Anti-Infective Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Drugs for Anti-Infective by Countries
  7.1.1 Europe Drugs for Anti-Infective Consumption by Countries (2013-2018)
  7.1.2 Europe Drugs for Anti-Infective Value by Countries (2013-2018)
7.2 Europe Drugs for Anti-Infective Consumption by Type
7.3 Europe Drugs for Anti-Infective Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Anti-Infective by Countries
  8.1.1 Middle East & Africa Drugs for Anti-Infective Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Drugs for Anti-Infective Value by Countries (2013-2018)
8.2 Middle East & Africa Drugs for Anti-Infective Consumption by Type
8.3 Middle East & Africa Drugs for Anti-Infective Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Drugs for Anti-Infective Distributors
10.3 Drugs for Anti-Infective Customer

11 GLOBAL DRUGS FOR ANTI-INFECTIVE MARKET FORECAST

11.1 Global Drugs for Anti-Infective Consumption Forecast (2018-2023)
11.2 Global Drugs for Anti-Infective Forecast by Regions
  11.2.1 Global Drugs for Anti-Infective Forecast by Regions (2018-2023)
  11.2.2 Global Drugs for Anti-Infective Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Drugs for Anti-Infective Forecast by Type
11.8 Global Drugs for Anti-Infective Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GlaxoSmithKline
  12.1.1 Company Details
  12.1.2 Drugs for Anti-Infective Product Offered
  12.1.3 GlaxoSmithKline Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GlaxoSmithKline News
12.2 Merck
  12.2.1 Company Details
  12.2.2 Drugs for Anti-Infective Product Offered
  12.2.3 Merck Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Merck News
12.3 Pfizer
  12.3.1 Company Details
  12.3.2 Drugs for Anti-Infective Product Offered
  12.3.3 Pfizer Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer News
12.4 Novartis AG
  12.4.1 Company Details
  12.4.2 Drugs for Anti-Infective Product Offered
  12.4.3 Novartis AG Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Novartis AG News
12.5 Gilead Sciences
  12.5.1 Company Details
  12.5.2 Drugs for Anti-Infective Product Offered
  12.5.3 Gilead Sciences Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Gilead Sciences News
12.6 Abbott
  12.6.1 Company Details
  12.6.2 Drugs for Anti-Infective Product Offered
  12.6.3 Abbott Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Abbott News
12.7 Wyeth
  12.7.1 Company Details
  12.7.2 Drugs for Anti-Infective Product Offered
  12.7.3 Wyeth Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Wyeth News
12.8 Sanofi-Aventis
  12.8.1 Company Details
  12.8.2 Drugs for Anti-Infective Product Offered
  12.8.3 Sanofi-Aventis Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Sanofi-Aventis News
12.9 Bristol-Myers Squibb
  12.9.1 Company Details
  12.9.2 Drugs for Anti-Infective Product Offered
  12.9.3 Bristol-Myers Squibb Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Bristol-Myers Squibb News
12.10 Johnson
  12.10.1 Company Details
  12.10.2 Drugs for Anti-Infective Product Offered
  12.10.3 Johnson Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Johnson News
12.11 Roche Pharma AG
12.12 Nanosphere
12.13 NanoViricides
12.14 Novabay Pharmaceuticals
12.15 Obetech
12.16 Optimer Pharmaceuticals
12.17 Basilea Pharmaceutica AG
12.18 Daiichi Sankyo
12.19 MerLion Pharma
12.20 Theravance

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Anti-Infective
Table Product Specifications of Drugs for Anti-Infective
Figure Drugs for Anti-Infective Report Years Considered
Figure Market Research Methodology
Figure Global Drugs for Anti-Infective Consumption Growth Rate 2013-2023 (K Units)
Figure Global Drugs for Anti-Infective Value Growth Rate 2013-2023 ($ Millions)
Table Drugs for Anti-Infective Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of OTC
Table Major Players of OTC
Figure Product Picture of Rx Drugs
Table Major Players of Rx Drugs
Table Global Consumption Sales by Type (2013-2018)
Table Global Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Figure Global Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Table Global Drugs for Anti-Infective Revenue by Type (2013-2018) ($ million)
Table Global Drugs for Anti-Infective Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Drugs for Anti-Infective Value Market Share by Type (2013-2018)
Table Global Drugs for Anti-Infective Sale Price by Type (2013-2018)
Figure Drugs for Anti-Infective Consumed in Hospital
Figure Global Drugs for Anti-Infective Market: Hospital (2013-2018) (K Units)
Figure Global Drugs for Anti-Infective Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Drugs for Anti-Infective Consumed in Drugs Store
Figure Global Drugs for Anti-Infective Market: Drugs Store (2013-2018) (K Units)
Figure Global Drugs for Anti-Infective Market: Drugs Store (2013-2018) ($ Millions)
Figure Global Drugs Store YoY Growth ($ Millions)
Figure Drugs for Anti-Infective Consumed in Other
Figure Global Drugs for Anti-Infective Market: Other (2013-2018) (K Units)
Figure Global Drugs for Anti-Infective Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Figure Global Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Table Global Drugs for Anti-Infective Value by Application (2013-2018)
Table Global Drugs for Anti-Infective Value Market Share by Application (2013-2018)
Figure Global Drugs for Anti-Infective Value Market Share by Application (2013-2018)
Table Global Drugs for Anti-Infective Sale Price by Application (2013-2018)
Table Global Drugs for Anti-Infective Sales by Players (2016-2018) (K Units)
Table Global Drugs for Anti-Infective Sales Market Share by Players (2016-2018)
Figure Global Drugs for Anti-Infective Sales Market Share by Players in 2016
Figure Global Drugs for Anti-Infective Sales Market Share by Players in 2017
Table Global Drugs for Anti-Infective Revenue by Players (2016-2018) ($ Millions)
Table Global Drugs for Anti-Infective Revenue Market Share by Players (2016-2018)
Figure Global Drugs for Anti-Infective Revenue Market Share by Players in 2016
Figure Global Drugs for Anti-Infective Revenue Market Share by Players in 2017
Table Global Drugs for Anti-Infective Sale Price by Players (2016-2018)
Figure Global Drugs for Anti-Infective Sale Price by Players in 2017
Table Global Drugs for Anti-Infective Manufacturing Base Distribution and Sales Area by Players
Table Players Drugs for Anti-Infective Products Offered
Table Drugs for Anti-Infective Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Drugs for Anti-Infective Consumption by Regions 2013-2018 (K Units)
Table Global Drugs for Anti-Infective Consumption Market Share by Regions 2013-2018
Figure Global Drugs for Anti-Infective Consumption Market Share by Regions 2013-2018
Table Global Drugs for Anti-Infective Value by Regions 2013-2018 ($ Millions)
Table Global Drugs for Anti-Infective Value Market Share by Regions 2013-2018
Figure Global Drugs for Anti-Infective Value Market Share by Regions 2013-2018
Figure Americas Drugs for Anti-Infective Consumption 2013-2018 (K Units)
Figure Americas Drugs for Anti-Infective Value 2013-2018 ($ Millions)
Figure APAC Drugs for Anti-Infective Consumption 2013-2018 (K Units)
Figure APAC Drugs for Anti-Infective Value 2013-2018 ($ Millions)
Figure Europe Drugs for Anti-Infective Consumption 2013-2018 (K Units)
Figure Europe Drugs for Anti-Infective Value 2013-2018 ($ Millions)
Figure Middle East & Africa Drugs for Anti-Infective Consumption 2013-2018 (K Units)
Figure Middle East & Africa Drugs for Anti-Infective Value 2013-2018 ($ Millions)
Table Americas Drugs for Anti-Infective Consumption by Countries (2013-2018) (K Units)
Table Americas Drugs for Anti-Infective Consumption Market Share by Countries (2013-2018)
Figure Americas Drugs for Anti-Infective Consumption Market Share by Countries in 2017
Table Americas Drugs for Anti-Infective Value by Countries (2013-2018) ($ Millions)
Table Americas Drugs for Anti-Infective Value Market Share by Countries (2013-2018)
Figure Americas Drugs for Anti-Infective Value Market Share by Countries in 2017
Table Americas Drugs for Anti-Infective Consumption by Type (2013-2018) (K Units)
Table Americas Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Figure Americas Drugs for Anti-Infective Consumption Market Share by Type in 2017
Table Americas Drugs for Anti-Infective Consumption by Application (2013-2018) (K Units)
Table Americas Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Figure Americas Drugs for Anti-Infective Consumption Market Share by Application in 2017
Figure United States Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure United States Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Canada Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Canada Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Mexico Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Mexico Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Table APAC Drugs for Anti-Infective Consumption by Countries (2013-2018) (K Units)
Table APAC Drugs for Anti-Infective Consumption Market Share by Countries (2013-2018)
Figure APAC Drugs for Anti-Infective Consumption Market Share by Countries in 2017
Table APAC Drugs for Anti-Infective Value by Countries (2013-2018) ($ Millions)
Table APAC Drugs for Anti-Infective Value Market Share by Countries (2013-2018)
Figure APAC Drugs for Anti-Infective Value Market Share by Countries in 2017
Table APAC Drugs for Anti-Infective Consumption by Type (2013-2018) (K Units)
Table APAC Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Figure APAC Drugs for Anti-Infective Consumption Market Share by Type in 2017
Table APAC Drugs for Anti-Infective Consumption by Application (2013-2018) (K Units)
Table APAC Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Figure APAC Drugs for Anti-Infective Consumption Market Share by Application in 2017
Figure China Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure China Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Japan Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Japan Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Korea Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Korea Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure India Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure India Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Australia Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Australia Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Table Europe Drugs for Anti-Infective Consumption by Countries (2013-2018) (K Units)
Table Europe Drugs for Anti-Infective Consumption Market Share by Countries (2013-2018)
Figure Europe Drugs for Anti-Infective Consumption Market Share by Countries in 2017
Table Europe Drugs for Anti-Infective Value by Countries (2013-2018) ($ Millions)
Table Europe Drugs for Anti-Infective Value Market Share by Countries (2013-2018)
Figure Europe Drugs for Anti-Infective Value Market Share by Countries in 2017
Table Europe Drugs for Anti-Infective Consumption by Type (2013-2018) (K Units)
Table Europe Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Figure Europe Drugs for Anti-Infective Consumption Market Share by Type in 2017
Table Europe Drugs for Anti-Infective Consumption by Application (2013-2018) (K Units)
Table Europe Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Figure Europe Drugs for Anti-Infective Consumption Market Share by Application in 2017
Figure Germany Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Germany Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure France Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure France Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure UK Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure UK Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Italy Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Italy Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Russia Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Russia Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Spain Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Spain Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Drugs for Anti-Infective Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Countries in 2017
Table Middle East & Africa Drugs for Anti-Infective Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Drugs for Anti-Infective Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Anti-Infective Value Market Share by Countries in 2017
Table Middle East & Africa Drugs for Anti-Infective Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Type in 2017
Table Middle East & Africa Drugs for Anti-Infective Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Drugs for Anti-Infective Consumption Market Share by Application in 2017
Figure Egypt Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Egypt Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure South Africa Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure South Africa Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Israel Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Israel Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure Turkey Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure Turkey Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Drugs for Anti-Infective Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Drugs for Anti-Infective Value Growth 2013-2018 ($ Millions)
Table Drugs for Anti-Infective Distributors List
Table Drugs for Anti-Infective Customer List
Figure Global Drugs for Anti-Infective Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Drugs for Anti-Infective Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Drugs for Anti-Infective Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Drugs for Anti-Infective Consumption Market Forecast by Regions
Table Global Drugs for Anti-Infective Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Drugs for Anti-Infective Value Market Share Forecast by Regions
Figure Americas Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Americas Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure APAC Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure APAC Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Europe Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Europe Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Middle East & Africa Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Middle East & Africa Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure United States Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure United States Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Canada Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Canada Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Mexico Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Mexico Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Brazil Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Brazil Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure China Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure China Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Japan Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Japan Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Korea Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Korea Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Southeast Asia Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Southeast Asia Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure India Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure India Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Australia Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Australia Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Germany Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Germany Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure France Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure France Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure UK Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure UK Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Italy Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Italy Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Russia Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Russia Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Spain Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Spain Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Egypt Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Egypt Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure South Africa Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure South Africa Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Israel Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Israel Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure Turkey Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure Turkey Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Figure GCC Countries Drugs for Anti-Infective Consumption 2018-2023 (K Units)
Figure GCC Countries Drugs for Anti-Infective Value 2018-2023 ($ Millions)
Table Global Drugs for Anti-Infective Consumption Forecast by Type (2018-2023) (K Units)
Table Global Drugs for Anti-Infective Consumption Market Share Forecast by Type (2018-2023)
Table Global Drugs for Anti-Infective Value Forecast by Type (2018-2023) ($ Millions)
Table Global Drugs for Anti-Infective Value Market Share Forecast by Type (2018-2023)
Table Global Drugs for Anti-Infective Consumption Forecast by Application (2018-2023) (K Units)
Table Global Drugs for Anti-Infective Consumption Market Share Forecast by Application (2018-2023)
Table Global Drugs for Anti-Infective Value Forecast by Application (2018-2023) ($ Millions)
Table Global Drugs for Anti-Infective Value Market Share Forecast by Application (2018-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Drugs for Anti-Infective Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Drugs for Anti-Infective Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Drugs for Anti-Infective Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG Drugs for Anti-Infective Market Share (2016-2018)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Gilead Sciences Drugs for Anti-Infective Market Share (2016-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Drugs for Anti-Infective Market Share (2016-2018)
Table Wyeth Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wyeth Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Wyeth Drugs for Anti-Infective Market Share (2016-2018)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi-Aventis Drugs for Anti-Infective Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Drugs for Anti-Infective Market Share (2016-2018)
Table Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson Drugs for Anti-Infective Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson Drugs for Anti-Infective Market Share (2016-2018)
Table Roche Pharma AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nanosphere Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NanoViricides Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novabay Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Obetech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Optimer Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Basilea Pharmaceutica AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MerLion Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Theravance Basic Information, Manufacturing Base, Sales Area and Its Competitors